Summit Corporation plc Stock London S.E.
Stocks
GB00B02T3K57
Biotechnology & Medical Research
|
End-of-day quote
London S.E.
|
||
| - GBX | - |
|
| Market Cap | 10.16B 13.49B 11.88B 11.26B 19.15B 1,293B 19.4B 135B 51.82B 661B 50.65B 49.55B 2,120B | P/E 2026 * |
-14.7x | P/E 2027 * | -14.5x |
|---|---|---|---|---|---|
| Enterprise Value | 9.69B 12.87B 11.33B 10.73B 18.27B 1,234B 18.5B 128B 49.42B 631B 48.31B 47.26B 2,022B | EV / Sales 2026 * |
3,305x | EV / Sales 2027 * | 238x |
| Free-Float |
19.11% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Summit Corporation plc
| Manager | Title | Age | Since |
|---|---|---|---|
Mahkam Zanganeh
CEO | Chief Executive Officer | 55 | 2022-07-24 |
Robert Duggan
CEO | Chief Executive Officer | 81 | 2020-03-31 |
| Director of Finance/CFO | 48 | 2024-04-01 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Duggan
CHM | Chairman | 81 | 2020-01-31 |
| Director/Board Member | 48 | 2019-11-30 | |
Mahkam Zanganeh
BRD | Director/Board Member | 55 | 2020-11-10 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.16% | -0.36% | +49.37% | +94.17% | 74.46B | |
| -0.61% | +0.84% | +27.28% | +80.26% | 60.14B | |
| -2.56% | -1.51% | +5.01% | +33.51% | 48.15B | |
| -1.55% | -3.67% | +30.00% | +36.64% | 44.25B | |
| +2.23% | +4.93% | +357.28% | +701.34% | 43.99B | |
| -0.68% | +0.90% | +8.37% | +103.47% | 41.61B | |
| +3.32% | +3.49% | +11.18% | +51.23% | 29.97B | |
| +4.77% | +6.16% | +36.77% | +22.78% | 29.31B | |
| -2.53% | -8.43% | -24.43% | +338.71% | 24.93B | |
| Average | +0.72% | +1.97% | +55.65% | +162.46% | 44.09B | |
| Weighted average by Cap. | +0.82% | +1.83% | +59.87% | +153.42% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.93M 3.89M 3.43M 3.25M 5.53M 373M 5.6M 38.86M 14.95M 191M 14.62M 14.3M 612M | 41.86M 55.57M 48.94M 46.37M 78.9M 5.33B 79.92M 555M 213M 2.72B 209M 204M 8.73B |
| Net income | -698M -927M -816M -773M -1.32B -88.86B -1.33B -9.25B -3.56B -45.43B -3.48B -3.4B -146B | -740M -983M -865M -820M -1.4B -94.24B -1.41B -9.81B -3.78B -48.18B -3.69B -3.61B -154B |
| Net Debt | -470M -624M -549M -521M -886M -59.82B -897M -6.23B -2.4B -30.58B -2.34B -2.29B -98.04B | -200M -266M -234M -222M -377M -25.48B -382M -2.65B -1.02B -13.02B -998M -976M -41.75B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
